Requires Strategy on China Biotech Threats
HR10859-119 · Introduced Oct 22, 2026
Why it matters
Biotech companies and researchers could face more government review of foreign investments and partnerships. Congress would get regular reports on China's biotech activity.
What it does
- Requires the Defense Department to write a strategy on biotech threats from foreign adversaries, especially China
- Requires a national intelligence assessment of China's military use of biotechnology within 180 days
- Creates a Biotechnology Risk Contact Group to monitor foreign investment in U.S. biotech firms
- Requires briefings to Congress every 90 days on the group's work
In committee
Next: a committee vote
- Introduceddone
- Committeecurrent step
- Housenot yet
- Senatenot yet
- Presidentnot yet
About this bill
Would require the Defense Department to write a strategy on biotech threats from foreign adversaries, especially China, and create a monitoring group for foreign biotech investment.
Biotech Defense Act
Perspectives
💬 The case for
National security groups would likely say China's biotech growth is a real military threat. They would say the strategy and reports help protect sensitive data and technology.
💬 The case against
Some biotech companies would likely say the reviews could slow research and foreign partnerships. Privacy groups may also worry about data collected through the new monitoring database.
Sponsored by
Sponsor details for this federal bill are at the source link.
News
Loading coverage…